|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/735 | (2006.01) |
| C07K 14/00 | (2006.01) | ||
| C12N 15/85 | (2006.01) |
| (11) | Number of the document | 3129400 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15718060.5 |
| Date of filing the European patent application | 2015-04-08 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation | 2020-06-25 |
| (86) | Number | PCT/US2015/024920 |
| Date | 2015-04-08 |
| (87) | Number | WO 2015/157415 |
| Date | 2015-10-15 |
| (30) | Number | Date | Country code |
| 201461977037 P | 2014-04-08 | US |
| (72) |
MURPHY, Andrew J., US
MACDONALD, Lynn, US
GURER, Cagan, US
MEAGHER, Karolina A., US
TU, Naxin, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Gyvūnai, išskyrus žmogų, turintys humanizuotus Fc-gama receptorius |
| NON-HUMAN ANIMALS HAVING HUMANIZED Fc-GAMMA RECEPTORS |
| Payment date | Validity (years) | Amount | |
| 2025-03-19 | 11 | 289.00 EUR |
| 2026-04-08 |